Default Category
-
Zebra Medical Vision (Spanish version)
Greenstein, Shane; Gulick, SarahCase HBS-620S05EntrepreneurshipWhat should they do next at Zebra? Should they work on the accuracy of the already-developed algorithms, or continue to develop many new tools? If they chose to develop new products, which applications should they address? And how should they go to market?Starting at €8.20
-
Israel at 70: Is it Possible to (re)Brand a Country
Ofek, Elie; Gulick, SarahCase HBS-519006-EMarketingIn the spring of 2018, Israel was set to celebrate its 70th anniversary. While there was much to rejoice in reaching this milestone, the country's brand image internationally was far from ideal. Past efforts to impact perceptions of Israel, spearheaded by the Ministry of Foreign Affairs as well as various Jewish organizations, were mainly aimed at "explaining" Israel's political position and convincing the world that the country was acting in a j...Starting at €8.20
-
Zebra Medical Vision
Greenstein, Shane; Gulick, SarahCase HBS-619014-EEntrepreneurshipAn Israeli startup founded in 2014, Zebra Medical Vision, develops algorithms that produced diagnoses from X-rays, mammograms, and CT-scans. The algorithms used deep learning and digitized radiology scans to create software that could assist doctors in making diagnoses. By July 2018, Zebra had developed seven algorithms to analyze scans for emphysema, liver density, compression fractures, bone density, brain bleeds, breast cancer, and a calcium s...Starting at €8.20
-
Zebra Medical Vision, Teaching Note
Greenstein, Shane; Gulick, SarahTeaching Note HBS-619053-EEntrepreneurshipTeaching note is meant to accompany Zebra Medical Vision case, which offers a look at a company's decisions as a small startup competing with other startups and major technology companies. It also demonstrates the challenges faced by a machine learning company working on brand-new technology, including difficulties finding training data, hiring competition, and negotiating FDA approvals and other government regulations.Starting at €0.00
-
The New M&A Playbook (Spanish version)
Christensen, Clayton M.; Alton, Richard; Rising, Curtis; Waldeck, AndrewArticle HBS-R1103BStrategyCompanies spend more than $2 trillion on acquisitions every year, yet the M&A failure rate is between 70% and 90%. Executives can dramatically increase their odds of success, the authors argue, if they understand how to select targets, how much to pay for them, and whether and how to integrate them. The most common reasons for making an acquisition include holding on to a premium position or cutting costs. But to realize those benefits, the acqui...Starting at €8.20
-
Purpose Brands
McDonald, Rory; Christensen, Clayton M.; Roseman, ShayeCase HBS-619075-EInformation TechnologiesFor Asian Agri and other Indonesian palm oil producers, the future promised rising demand from fast-growing Asian populations, but also intensifying criticism from environmental groups. With the highest yield and lowest production cost of any edible oil, palm oil constituted an abundant, inexpensive source of food for Asian and, to a lesser extent, international markets. Its production had soared from 1970 to 2010, sparking concern from environme...Starting at €8.20